GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BerGenBio ASA (OSL:BGBIO) » Definitions » Change In Other Working Capital

BerGenBio ASA (OSL:BGBIO) Change In Other Working Capital : kr-14.56 Mil (TTM As of Dec. 2024)


View and export this data going back to 2017. Start your Free Trial

What is BerGenBio ASA Change In Other Working Capital?

BerGenBio ASA's Change In Other Working Capital for the quarter that ended in Dec. 2024 was kr-9.42 Mil. It means BerGenBio ASA's Other Working Capital declined by kr9.42 Mil from Sep. 2024 to Dec. 2024 .

BerGenBio ASA's Change In Other Working Capital for the fiscal year that ended in Dec. 2024 was kr-14.56 Mil. It means BerGenBio ASA's Other Working Capital declined by kr14.56 Mil from Dec. 2023 to Dec. 2024 .

BerGenBio ASA Change In Other Working Capital Historical Data

The historical data trend for BerGenBio ASA's Change In Other Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BerGenBio ASA Change In Other Working Capital Chart

BerGenBio ASA Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Change In Other Working Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 15.92 -1.77 12.67 -31.81 -14.56

BerGenBio ASA Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Change In Other Working Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 20.08 -4.60 1.20 -1.74 -9.42

BerGenBio ASA Change In Other Working Capital Calculation

Change In Other Working Capital is any increase or decrease between periods of other working capital that are not otherwise classified.

Change In Other Working Capital for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-14.56 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BerGenBio ASA Change In Other Working Capital Related Terms

Thank you for viewing the detailed overview of BerGenBio ASA's Change In Other Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

BerGenBio ASA Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BerGenBio ASA (OSL:BGBIO) » Definitions » Change In Other Working Capital
Comparable Companies
OSL:PCIB OSL:ABS OSL:CRNA OSL:EXTX OSL:SOFTX OSL:ONCIN OSL:ABTEC OSL:ZLNA VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX SMMT RPRX
Traded in Other Exchanges
0RU5:UK 7BG0:Germany
Address
Nygardsgaten 114, Bergen, NOR, 5008
Website
https://www.bergenbio.com
BerGenBio ASA is a clinical-stage biopharmaceutical company developing drugs for aggressive diseases, including drug resistant and metastatic cancers and respiratory disease. Its product, bemcentinib (BGB324), is a selective, potent, oral small molecule AXL inhibitor that has been tested in a various indications including NSCLC, AML and severe respiratory infections.

BerGenBio ASA Headlines

No Headlines